Medicare will soon negotiate prices for 15 more drugs as part of an effort to reduce costs for seniors and people with ...
As part of the Inflation Reduction Act, price negotiations with manufacturers will begin this year, with reduced prices ...
The Health and Human Services Department won’t issue health advisories, reports or other materials until further notice, the ...
The rescinded order directed Medicare and Medicaid to test ways to lower drug costs for enrollees. Those tests hadn’t started ...
A report from The Lancet Diabetes & Endocrinology Commission has proposed new criteria for defining and diagnosing obesity, ...
Abe Sutton, a health policy aide in the first Trump administration, is likely to be named head of the Center for Medicare and ...
The Biden Administration announced the next batch of 15 prescription drugs that will be included in price negotiations with companies — with the aim of lowering costs for people covered by Medicare.
Ozempic and Wegovy, Novo Nordisk’s GLP-1 drugs that treat diabetes and obesity, are on the list. Astellas Pharma’s prostate cancer drug, Xtandi, is also on the list — alongside AstraZeneca’s cancer ...
Meena Seshamani’s Medicare swan song ended on a note of bravura: the announcement that 15 costly drugs, including Novo ...
Experts suggest that most Americans will not experience immediate changes in their out-of-pocket health care expenses.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback